Acute circulatory failure that combines hypovolemia, vasoplegia and cardiac dysfunction plays a major role in the development of sepsis-related organ dysfunction. Pathophysiological mechanisms are multiple and complex. The objective of the GENESIS study is to determine the impact of early haemodynamic assessment using echocardiography in association with a therapeutic algorithm (intervention arm), when compared with standard of care based on the current Surviving Sepsis Campaign (SSC) recommendations (control arm), on the development of organ dysfunctions in patients admitted to the Emergency Department for sepsis or septic shock.
Sepsis is currently defined as life-threatening organ dysfunction secondary to a dysregulated host response to infection (Sepsis-3). Septic shock is a subgroup of patients who also have sustained arterial hypotension requiring vasopressors and tissue dysoxia. The mortality varies from 10 to 40% depending on the severity. The latest "bundles" of the SSC request to perform within the first hour of sepsis identification a fluid loading of 30 mL/kg of crystalloids in the presence of hypotension, and to initiate a vasopressor support in case of persistent hypotension to maintain a mean arterial pressure ≥ 65 mmHg. However, early fluid resuscitation is not necessarily associated with an improvement of sepsis prognosis and may even be deleterious when leading to excessive positive fluid balance. Accordingly, the SSC recommends investigating a personalized approach to define for each patient the appropriate volume of fluids to be administered according to the initial mechanism of sepsis-induced cardiovascular failure. Echocardiography is currently recommended as a first-line modality to identify the origin of acute circulatory failure, sepsis remaining the leading cause. It has been shown to alter ongoing treatment based on the sole SSC recommendations in the intensive care unit. In contrast, the impact of hemodynamic assessment using echocardiography at the early stage of sepsis in patients admitted to the Emergency Department (ED) is unknown. In this randomized trial, patients will be either assessed hemodynamically using transthoracic echocardiography to guide early therapeutic management (intervention arm) or managed according to standards of care based on current SSC recommendations (control arm). Early echocardiography will be performed after 500 mL of fluid loading initiated upon identification of septic patients based on the qSOFA score (hemodynamic criterion required: systolic blood pressure ≤ 100 mmHg). This will allow identifying the hemodynamic profile at the origin of sepsis-induced circulatory failure and to monitor both the efficacy and tolerance of fluid resuscitation, or of any other therapeutic intervention (e.g., inotropic support) according to a predefined therapeutic algorithm. Patients allocated to the control arm will be managed conventionally according to current SSC recommendations, including a standardized fluid loading of 30 mL/kg. Organ dysfunctions will be assessed in the two study arms by the SOFA score 24 hours after randomization and patient will be followed up until hospital discharge to determine outcome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
312
In the intervention arm, echocardiography will be performed immediately and potentially repeated to confirm the need for additional fluid resuscitation up to 30 mL/kg in the presence of persisting hypovolemia, or not (e.g., severe ventricular dysfunction). A therapeutic algorithm will allow standardized impact on ongoing management according to the hemodynamic profile identified by early echocardiography. After the completion of initial fluid resuscitation up to 30 mL/kg if required, a new echocardiographic assessment will be systematically performed by the same operator to stop or not fluid resuscitation, and to potentially initiate another treatment according to both the hemodynamic profile and clinical context.
In the control arm, patients will be treated according to standards of care based on current SSC recommendations, including a fluid resuscitation of 30 mL/kg.
CH d'Albi
Albi, France
CH d'Eaubonne - Montmorency
Eaubonne, France
Grenoble university hospital
La Tronche, France
Limgoes university hospital
Limoges, France
Hospices civils de Lyon
Lyon, France
Nantes university hospital
Nantes, France
Nice university hospital
Nice, France
Poitiers university hospital
Poitiers, France
La réunion university hospital
Saint-Pierre, France
Toulouse university hospital
Toulouse, France
Change in Sequential Organ Failure Assessment (SOFA) score
Crude variation of the SOFA score between inclusion and 24h following randomization.
Time frame: change from Hour 0 at Day 1
Interruption of fluid resuscitation
Number and proportion of patients in whom echocardiography performed in the ED (intervention arm) modified ongoing therapy based on SSC recommendations (standard of care) according to the hemodynamic profile. Interruption of fluid resuscitation before having administrated 30 mL/kg
Time frame: Hour 3
Maintains of fluid resuscitation
Number and proportion of patients in whom echocardiography performed in the ED (intervention arm) modified ongoing therapy based on SSC recommendations (standard of care) according to the hemodynamic profile. Fluid resuscitation maintained beyond 30 mL/kg
Time frame: Hour 3
Initiation of inotropes
Number and proportion of patients in whom echocardiography performed in the ED (intervention arm) modified ongoing therapy based on SSC recommendations (standard of care) according to the hemodynamic profile. Initiation of inotropes
Time frame: Hour 3
Initiation of vasopressor support
Number and proportion of patients in whom echocardiography performed in the ED (intervention arm) modified ongoing therapy based on SSC recommendations (standard of care) according to the hemodynamic profile. Initiation of vasopressor support
Time frame: Hour 3
Therapeutic modification
Number and proportion of patients in whom echocardiography performed in the ED (intervention arm) modified ongoing therapy based on SSC recommendations (standard of care) according to the hemodynamic profile. Therapeutic modification directly related to the echocardiographic examination
Time frame: Hour 3
Persisting hypovolemia
Number and proportion of patients presenting at the time of early hemodynamic assessment using echocardiography (intervention arm)
Time frame: Hour 0
Left ventricular failure
Number and proportion of patients presenting at the time of early hemodynamic assessment using echocardiography (intervention arm)
Time frame: Hour 0
Vasoplegia with left ventricular hyperkinesia
Number and proportion of patients presenting at the time of early hemodynamic assessment using echocardiography (intervention arm)
Time frame: Hour 0
Right ventricular failure
Number and proportion of patients presenting at the time of early hemodynamic assessment using echocardiography (intervention arm)
Time frame: Hour 0
Stabilized hemodynamic status
Number and proportion of patients presenting at the time of early hemodynamic assessment using echocardiography (intervention arm). Stabilized hemodynamic status (none of above-mentioned abnormalities) due to adequate management of acute circulatory failure (avoid any deleterious therapeutic change).
Time frame: Hour 0
Hydrostatic pulmonary edema
Number of Hydrostatic pulmonary edema (cardiogenic or volume overload) since potentially related to excessive fluid loading
Time frame: through study completion, an average of 1 month
Supraventricular arrhythmias
Number of Supraventricular arrhythmias since potentially related to the initiation of positive inotropes
Time frame: through study completion, an average of 1 month
ventricular arrhythmias
Number of ventricular arrhythmias since potentially related to the initiation of positive inotropes
Time frame: through study completion, an average of 1 month
acute coronary syndrome,
Number of acute coronary syndrome since potentially related to the initiation of positive inotropes
Time frame: through study completion, an average of 1 month
ischemic stroke
Number of ischemic stroke since potentially related to the initiation of positive inotropes
Time frame: through study completion, an average of 1 month
hemorrhagic stroke
Number of hemorrhagic stroke since potentially related to the initiation of positive inotropes
Time frame: through study completion, an average of 1 month
Lactate clearance
Lactate clearance (lactate 6h after randomization compared to lactate at baseline)
Time frame: Hour 0 to Hour 6
septic shock
Number and proportion of patients who developed septic shock 24 h after inclusion
Time frame: Hour 24
Patient course
Patient course after emergency department discharge: hospitalization in regular ward (medicine / surgery), stepdown unit or intensive care unit.
Time frame: through study completion, an average of 1 month
Mortality
Mortality (all-cause and sepsis-related) at Day 7 and at hospital discharge
Time frame: Day 7 and through study completion, an average of 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.